Home > Qtrly Results > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Mar2024]

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹930 Cr ₹805 Cr ₹957 Cr ₹762 Cr ₹787 Cr ₹802 Cr ₹917 Cr ₹745 Cr
Expenses ₹673 Cr ₹587 Cr ₹668 Cr ₹618 Cr ₹618 Cr ₹574 Cr ₹660 Cr ₹596 Cr
Operating Income ₹257 Cr ₹218 Cr ₹289 Cr ₹144 Cr ₹170 Cr ₹229 Cr ₹257 Cr ₹149 Cr
Other Income ₹30 Cr ₹28 Cr ₹28 Cr ₹36 Cr ₹28 Cr ₹23 Cr ₹22 Cr ₹28 Cr
Interest ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Depreciation ₹18 Cr ₹17 Cr ₹18 Cr ₹16 Cr ₹17 Cr ₹16 Cr ₹16 Cr ₹16 Cr
Profit Before Tax ₹271 Cr ₹65 Cr ₹299 Cr ₹181 Cr ₹190 Cr ₹224 Cr ₹262 Cr ₹160 Cr
Profit After Tax ₹194 Cr ₹46 Cr ₹218 Cr ₹132 Cr ₹133 Cr ₹165 Cr ₹193 Cr ₹116 Cr
EPS ₹11.48 ₹2.70 ₹12.84 ₹7.81 ₹7.88 ₹9.71 ₹11.42 ₹7.04
Industry Peers & Returns1W1M1Y
GLAXOSMITHKLINE PHARMACEUTICALS 3.2% 16.9% 90.5%
SUN PHARMACEUTICAL INDUSTRIES -2.9% 0% 59.6%
CIPLA 5.8% 6.2% 60.9%
DR REDDYS LABORATORIES 0.9% -1.5% 32.2%
ZYDUS LIFESCIENCES -2.6% 15.3% 114.4%
DIVIS LABORATORIES 5% 8% 25.9%
MANKIND PHARMA -2.3% -14% 57.7%
TORRENT PHARMACEUTICALS -3.4% -2.7% 61.2%
LUPIN -2.8% 2.1% 110.5%

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

15.47 %

Y-o-Y

18.08 %

Quarters Revenues % Change
Mar2024 ₹930 Cr
15.47
Dec2023 ₹805 Cr
-15.85
Sep2023 ₹957 Cr
25.65
Jun2023 ₹762 Cr
-3.28
Mar2023 ₹787 Cr
-1.85
Dec2022 ₹802 Cr
-12.50
Sep2022 ₹917 Cr
23.05
Jun2022 ₹745 Cr -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

17.98 %

Y-o-Y

51.56 %

Quarters Operating Profit % Change
Mar2024 ₹257 Cr
17.98
Dec2023 ₹218 Cr
-24.67
Sep2023 ₹289 Cr
101.20
Jun2023 ₹144 Cr
-15.24
Mar2023 ₹170 Cr
-25.78
Dec2022 ₹229 Cr
-10.99
Sep2022 ₹257 Cr
72.53
Jun2022 ₹149 Cr -
Operating Margins
Q-o-Q

2.18 %

Y-o-Y

28.34 %

Quarters Operating Margin% % Change
Mar2024 27.67%
2.18
Dec2023 27.08%
-10.48
Sep2023 30.25%
60.14
Jun2023 18.89%
-12.38
Mar2023 21.56%
-24.38
Dec2022 28.51%
1.75
Sep2022 28.02%
40.17
Jun2022 19.99% -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

325.37 %

Y-o-Y

45.75 %

Quarters Profit After Tax % Change
Mar2024 ₹194 Cr
325.37
Dec2023 ₹46 Cr
-78.98
Sep2023 ₹218 Cr
64.47
Jun2023 ₹132 Cr
-0.88
Mar2023 ₹133 Cr
-18.92
Dec2022 ₹165 Cr
-14.92
Sep2022 ₹193 Cr
66.41
Jun2022 ₹116 Cr -
PAT Margins
Q-o-Q

268.31 %

Y-o-Y

23.49 %

Quarters PAT Margin(%) % Change
Mar2024 20.92 %
268.31
Dec2023 5.68 %
-75.01
Sep2023 22.73 %
30.93
Jun2023 17.36 %
2.48
Mar2023 16.94 %
-17.41
Dec2022 20.51 %
-2.80
Sep2022 21.1 %
35.26
Jun2022 15.6 % -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

325.19 %

Y-o-Y

45.69 %

Quarters EPS % Change
Mar2024 ₹11.48
325.19
Dec2023 ₹2.7
-78.97
Sep2023 ₹12.84
64.40
Jun2023 ₹7.81
-0.89
Mar2023 ₹7.88
-18.85
Dec2022 ₹9.71
-14.97
Sep2022 ₹11.42
62.22
Jun2022 ₹7.04 -

You may also like the below Video Courses